ArticleOncogene2019

Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.

Ye Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.